We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAP icon
201
Advance Auto Parts
AAP
$3.59B
$203K ﹤0.01%
+3,630
New +$243K
CYTO
202
DELISTED
Altamira Therapeutics Ltd
CYTO
$203K ﹤0.01%
+41,450
New +$294K
ALLR
203
Allarity Therapeutics
ALLR
$21.2M
$195K ﹤0.01%
+435
New +$557K
NXGLW icon
204
NexGel Inc Warrant
NXGLW
$31.4K
$187K ﹤0.01%
550,000
– –
FGIWW
205
FGI Industries Warrant
FGIWW
$300K
$187K ﹤0.01%
933,333
– –
TU icon
206
Telus
TU
$15.4B
$177K ﹤0.01%
+10,825
New +$191K
DBGI
207
Digital Brands Group
DBGI
$9.36M
$170K ﹤0.01%
+10
New +$244K
ATHX
208
DELISTED
Athersys, Inc. Common Stock
ATHX
$165K ﹤0.01%
383,000
-1,560,000
-80% -$852K
AAL icon
209
American Airlines Group
AAL
$11B
$163K ﹤0.01%
+12,713
New +$197K
MYSZ icon
210
My Size
MYSZ
$1.86M
$153K ﹤0.01%
+22,125
New +$228K
DCOY
211
Decoy Therapeutics
DCOY
$2.23M
$148K ﹤0.01%
156
+80
+105% +$106K
VTAK icon
212
Catheter Precision
VTAK
$996K
$137K ﹤0.01%
1,617
+517
+47% +$60.1K
CUEN
213
DELISTED
Cuentas Inc. Common Stock
CUEN
$131K ﹤0.01%
+93,697
New +$297K
TCBP
214
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
$128K ﹤0.01%
93
-72
-44% -$119K
AREB
215
DELISTED
American Rebel
AREB
– –
0
– –
SKYAW
216
SkyAI Inc
SKYAW
$255K
$124K ﹤0.01%
1,176,000
– –
STKH
217
Steakholder Foods
STKH
$1.52M
$103K ﹤0.01%
98
-573
-85% -$709K
BEATW icon
218
Heartbeam Inc Warrant
BEATW
$59.1K
$100K ﹤0.01%
500,000
– –
SBEV.WS
219
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$90.4K ﹤0.01%
904,000
– –
FRMM
220
Forum Markets
FRMM
$82.3M
$80.2K ﹤0.01%
+689
New +$103K
CINGW icon
221
Cingulate Inc Warrants
CINGW
$31.8K
$67.7K ﹤0.01%
410,000
– –
PETVW
222
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$66K ﹤0.01%
200,000
– –
HIND
223
Vyome Holdings
HIND
$15M
$63.5K ﹤0.01%
+32
New +$209K
MTEKW icon
224
Maris-Tech Ltd Warrants
MTEKW
$1.16M
$63.1K ﹤0.01%
1,261,058
– –
FEED
225
ENvue Medical Inc
FEED
$3.63M
$57.2K ﹤0.01%
+264
New +$78.6K
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.